JoannaACooperMD

PubMed

• 304 citations
  Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
  Jerry S. Wolinsky, Ponnada A. Narayana, Paul O'Connor, P. K. Coyle, Corey C. Ford
  Annals of Neurology. 2007-01-01
• 212 citations
  Factors that influence adherence with disease-modifying therapy in MS.
  Katherine Treadaway, Gary Cutter, Amber Salter, Sharon G. Lynch, James Simsarian
  Journal of Neurology. 2009-04-27
• 3 citations
  Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.
  Annika Anderson, William Rowles, Shane Poole, Ayushi Balan, Carolyn Bevan
  Annals of Clinical and Translational Neurology. 2023-11-01

Journal Articles

• Maximally tolerated vs Minimally Effective Dose: the case of rituximab in MS  
  Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel RP, Multiple Sclerosis, 8/1/2011
• Factors that influence adherence with disease-modifying therapy in MS  
  . J Neurol, 4/1/2009
• The Functional Index for Living with Multiple Sclerosis: Development and Validation of a New Quality of Life Questionnaire.  
  JM Wesson, JA Cooper, LS Jehle, SN Lockhart, K Draney, J Barber, MULTIPLE SCLEROSIS, 1/1/2009
• Troubleshooting for Intrathecal Baclofen TherapyTouch briefings  
  Cooper, J, US Neurological Disease, 1/1/2007
• Response of Intrathecal Baclofen Resistance to Dose Reduction  
  Cooper, J., Ridley, B., Neurology, 1/1/2006
•  
  Beck, R,, Chandler, D., Cole, S., Simon, J., Jacobs L., Kinkel, P., Selhorst, J., Rose, J., Cooper, J., Rice G., Murray, T., Sandrock, A., Ann Neurol, 1/1/2002
• UPPER AIRWAY OBSTRUCTION FOLLOWING TRANSESOPHAGEAL ECHOCARDIOGRAPHY  
  Saphir, R., Kerbavaz, R., Cooper, J., Schiller, N, Journal of the American Society of Echocardiography, 11/1/1997
• STATUS EPILEPTICUS MANIFESTING AS REVERSIBLE WERNICKE'S APHASIA  
  Knight, R., Cooper, J, Epilepsia, 1/1/1986
• AUTOSOMAL DOMINANT MOTOR NEURON DEGENERATION IN A BLACK FAMILY  
  JA Cooper, T. Nakada, R. Knight, R. Friedland, Annals of Neurology, 11/1/1983
• GLUCOSE INTOLERANCE DURING PREGNANCY; II) A COMPARATIVE STUDY OF DIAGNOSTIC SCREENING METHODS  
  A. Cooper, M. Granat, M. Sharf, Obstetrics and Gynecology, 4/1/1979
• GLUCOSE INTOLERANCE DURING PREGNANCY; I) A REAPPRAISAL OF ALLEGED SCREENING CRITERIA  
  M. Granat, M. Sharf, A. Cooper, Obstetrics and Gynecology, 2/1/1979
• Join now to see all

Abstracts/Posters

• Unique Characteristics of Patients with Multiple Sclerosis Receiving Intrathecal Baclofen Therapy
  JA Cooper, B Ridley, LS Jehle, JM Wesson, Submitted for poster presentation at ECTRIMS 2013, 1/1/2013
• Multiple Sclerosis Disease Severity Correlates with Perception Of Clinic visit effectiveness when using Quality Of Life Assessment
  Sara KosterMark Wesson, Myesha Kirk-Junior, Victoria Nolan, Edward Fox, , Elliot Frohman, Gina Remington, Ardith Courtney, Lynn Jehle, Joanna Cooper, Submitted for poster presentation at ECTRIMS 2013, 1/1/2013
• The Utility Of The Functional Index For Living With Multiple Sclerosis In Clinical Practice
  J cooper et al., ECTRIMS, poster 1051, 10/1/2012
• Cell Depletion and Safety of Low Dose Rituximab in Patients with Relapsing Multiple Sclerosis
  Miravalle AA, Kinkel R, Langer-Gould A, Cooper J. B, American Academy of Neurology, 61st Annual Meeting, April-May, 4/1/2009
• The Functional Index for Living with Multiple Sclerosis: development and preliminary results
  Wesson JM, Cooper JA, Barber J, Lockhart SN, Draney K, Dalio J, Linton A, Multiple Sclerosis, World Conference on Treatment and Research in Multiple Sclerosis, 9/1/2008
• A multivariate analysis of factors that influence adherence with disease-modifying therapy in multiple sclerosis
  Treadaway K, Cutter G, Lynch SG, Corboy J, Simsarian J, Jeffery D, Cohen B, Mankowski K, Guarnaccia JB, Schaeffer L, Brandes D, Kaufman C, Duncan D, Marder E, Allen A,..., Multiple Sclerosis, World Conference on Treatment and Research in Multiple Sclerosis, 9/1/2008
• Efficacy of Alemtuzumab
  oanna A. Cooper, (On behalf of the CAMMS223 Study Group), Relapsing-Remitting Multiple Sclerosis is Independent of Baseline Status Consortium Of MS Centers (C, 5/1/2008
• Join now to see all

Other

• Multiple Sclerosis: A Practice Guide For Primary Care Providers. 
  JA Cooper, C. Figuerito, D. Foti, A Lily, D. Mohr, P Werfel.
  A CME Home Study Course. Alta Bates Medical Center and The Northern California Chapter of the Nation
• Multiple Sclerosis: A Practice Guide for Primary Care Providers 
  JA Cooper, E. Waubant, R. Young, D. Blanchard, K. Wharton, P. Werfel
  A CME Home Study Course, second edition. Alta Bates Medical Center and The Northern California Chapt